Literature DB >> 14962183

The avian B-cell receptor complex: distinct roles of Igalpha and Igbeta in B-cell development.

Kelly A Pike1, Ehtesham Baig, Michael J H Ratcliffe.   

Abstract

The bursa of Fabricius has evolved in birds as a gut-associated site of B-cell lymphopoiesis that is segregated from the development of other hematopoietic lineages. Despite differences in the developmental progression of chicken as compared to murine B-cell lymphopoiesis, cell-surface immunoglobulin (sIg) expression has been conserved in birds as an essential checkpoint in B-cell development. B-cell precursors that express an sIg complex that includes the evolutionarily conserved Igalpha/beta heterodimer colonize lymphoid follicles in the bursa, whereas B-cell precursors that fail to express sIg due to non-productive V(D)J recombination are eliminated. Productive retroviral gene transfer has allowed us to introduce chimeric receptor constructs into developing B-cell precursors in vivo. Chimeric proteins comprising the extracellular and transmembrane regions of murine CD8alpha fused to the cytoplasmic domain of chicken Igalpha efficiently supported B-cell development in precursors that lacked endogenous sIg expression. By contrast, expression of an equivalent chimeric receptor containing the cytoplasmic domain of Igbeta actively inhibited B-cell development. Consequently, the cytoplasmic domains of Igalpha and Igbeta play functionally distinct roles in chicken B-cell development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962183     DOI: 10.1111/j.0105-2896.2004.0111.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  11 in total

Review 1.  Evolution of immunity: no development without risk.

Authors:  Alexander B Sigalov
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  Cells diversify transmembrane signaling through the controlled chaos of protein disorder.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2011-04-01

3.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

4.  Differential occurrence of protein intrinsic disorder in the cytoplasmic signaling domains of cell receptors.

Authors:  Alexander B Sigalov; Vladimir N Uversky
Journal:  Self Nonself       Date:  2011-01-01

5.  B cell receptor accessory molecules in the channel catfish, Ictalurus punctatus.

Authors:  Manoranjan Sahoo; Eva-Stina Edholm; James L Stafford; Eva Bengtén; Norman W Miller; Melanie Wilson
Journal:  Dev Comp Immunol       Date:  2008-06-10       Impact factor: 3.636

6.  Negative selection of self-reactive chicken B cells requires B cell receptor signaling and is independent of the bursal microenvironment.

Authors:  Dariush Davani; Zeev Pancer; Hilde Cheroutre; Michael J H Ratcliffe
Journal:  J Immunol       Date:  2014-02-10       Impact factor: 5.422

7.  Identification of microRNA in the developing chick immune organs.

Authors:  Julie A Hicks; Prabhakar A Tembhurne; Hsiao-Ching Liu
Journal:  Immunogenetics       Date:  2009-02-06       Impact factor: 2.846

8.  Evaluation of the chicken transcriptome by SAGE of B cells and the DT40 cell line.

Authors:  Matthias B Wahl; Randolph B Caldwell; Andrzej M Kierzek; Hiroshi Arakawa; Eduardo Eyras; Nina Hubner; Christian Jung; Manuel Soeldenwagner; Manuela Cervelli; Yan-Dong Wang; Volkmar Liebscher; Jean-Marie Buerstedde
Journal:  BMC Genomics       Date:  2004-12-21       Impact factor: 3.969

9.  The potential molecular effects of bursal septpeptide II on immune induction and antitumor activity.

Authors:  Guang Fang Zhou; Qing Tao Liu; Bin Zhou; Ya Feng Qiu; Xiao Dong Liu; Zhi Yong Ma; Xiu Li Feng; Rui Bing Cao; Pu Yan Chen
Journal:  J Vet Sci       Date:  2015-01-30       Impact factor: 1.672

Review 10.  Targeting Intramembrane Protein-Protein Interactions: Novel Therapeutic Strategy of Millions Years Old.

Authors:  Alexander B Sigalov
Journal:  Adv Protein Chem Struct Biol       Date:  2017-07-24       Impact factor: 3.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.